These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23207810)

  • 1. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.
    Sahud M; Zhukov O; Mo K; Popov J; Dlott J
    Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FVIII and FIX inhibitors in people living with hemophilia in Cameroon, Africa: a preliminary study.
    Balôgôg PN; Tagny CT; Ndoumba A; Mbanya D
    Int J Lab Hematol; 2014 Oct; 36(5):566-70. PubMed ID: 25356499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors in congenital coagulation disorders.
    Key NS
    Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
    Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
    Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid syndrome diagnosis: an update].
    Visseaux B; Masliah-Planchon J; Fischer AM; Darnige L
    Ann Biol Clin (Paris); 2011; 69(4):411-8. PubMed ID: 21896405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
    Hay CR; Baglin TP; Collins PW; Hill FG; Keeling DM
    Br J Haematol; 2000 Oct; 111(1):78-90. PubMed ID: 11091185
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory identification of factor inhibitors: an update.
    Kershaw G; Favaloro EJ
    Pathology; 2012 Jun; 44(4):293-302. PubMed ID: 22531341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus anticoagulant, anticardiolipin antibodies, and human immunodeficiency virus in haemophilia.
    Cohen H; Mackie IJ; Anagnostopoulos N; Savage GF; Machin SJ
    J Clin Pathol; 1989 Jun; 42(6):629-33. PubMed ID: 2500459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta2-glycoprotein I dependent anticardiolipin antibodies and lupus anticoagulant in patients with recurrent pregnancy loss.
    Kumar KS; Jyothy A; Prakash MS; Rani HS; Reddy PP
    J Postgrad Med; 2002; 48(1):5-10. PubMed ID: 12082318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
    Kershaw G; Jayakodi D; Dunkley S
    Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
    Diniz MJ; Dias Francisco F; Tavares ML; Leal I
    Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors to clotting factors.
    Sallah S
    Ann Hematol; 1997; 75(1-2):1-7. PubMed ID: 9322677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study.
    Helgadottir LB; Skjeldestad FE; Jacobsen AF; Sandset PM; Jacobsen EM
    Thromb Res; 2012 Jul; 130(1):32-7. PubMed ID: 22178574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.